Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 18, 2019
Accession Number: 0001193125-19-262830
Submission Type: POS AM
CIK: 0001492422
Company Name: Apellis Pharmaceuticals, Inc.
File Number: 333-229091